PMID: 43753Dec 1, 1979

Pharmacotherapeutic trials in tardive dyskinesia

The British Journal of Psychiatry : the Journal of Mental Science
A V MacKay, G P Sheppard

Abstract

Some of the clinical factors contributing to the currently unsatisfactory state of therapy for tardive dyskinesia are reviewed. Problems such as lack of clear syndrome delineation and phenomenological description, the lack of standardization in rating scales and the lack of attention to trial design have all probably contributed to a rather confusing picture. Controlled trials suggest that several pharmacological agents may be of therapeutic value but that clinical prediction of an individual's response is impossible. The strategy of acute drug challenge has emerged as perhaps the most promising approach to the definition of pharmacological subtypes and therefore the choice of optimal treatment.

References

Jan 1, 1983·Psychopharmacology·J Hajioff, M Wallace
Jan 1, 1981·Psychopharmacology·R D Porsolt, M Jalfre
Jun 1, 1988·Biological Psychiatry·S P MahadikS E Karpiak
Jan 1, 1983·Progress in Neuro-psychopharmacology & Biological Psychiatry·S K RastogiY D Lapierre
Jan 1, 1988·Progress in Neuro-psychopharmacology & Biological Psychiatry·T MatsunagaK Fujimoto
Apr 3, 1999·Biological Psychiatry· AdityanjeeT Mathews
Aug 1, 1980·Psychological Medicine·A V MacKayC D Marsden
Mar 1, 1981·British Journal of Clinical Pharmacology·A V MacKay
Sep 1, 1992·The Japanese Journal of Psychiatry and Neurology·T NishikawaY Uchida
Apr 1, 1987·The British Journal of Psychiatry : the Journal of Mental Science·G G Fisk, S M York
Feb 1, 1981·British Journal of Clinical Pharmacology·C D Marsden, M Schachter
Oct 1, 1985·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·R Yassa

Citations

Jan 1, 1979·The Journal of Pharmacy and Pharmacology·M HofmannM Trabucchi
Aug 8, 1979·Psychopharmacology·G M SimpsonG Gardos
Sep 1, 1978·The British Journal of Psychiatry : the Journal of Mental Science·W E Haefely
Apr 1, 1975·Journal of the Neurological Sciences·L E ClaveriaI C Lodge-Patch
Mar 1, 1977·The Australian and New Zealand Journal of Psychiatry·S Metcalf, W Williams
Aug 1, 1978·Journal of Neurology, Neurosurgery, and Psychiatry·P A PriceC D Marsden
May 9, 1977·Psychopharmacology·G M SimpsonJ H Lee
Aug 31, 1977·Psychopharmacology·D E Casey, D Denney
Jul 1, 1979·The British Journal of Psychiatry : the Journal of Mental Science·H Freeman
Jan 1, 1978·The American Journal of Psychiatry·T R BarnesP J Taylor
Jan 1, 1978·The Journal of the Kentucky Medical Association·R P Granacher
May 4, 1978·The New England Journal of Medicine·J Keesey
Jun 1, 1978·American Journal of Surgery·P J HarbrechtD E Fry
Jul 1, 1976·Acta Psychiatrica Scandinavica·S Korsgaard
Aug 1, 1976·The British Journal of Psychiatry : the Journal of Mental Science·M LinnoilaO Kietala
Mar 1, 1976·Pharmakopsychiatrie, Neuro-Psychopharmakologie·G M SimpsonB Zoubok
Sep 8, 1977·The New England Journal of Medicine·J H GrowdonW Wiener
Sep 1, 1977·American Journal of Surgery·J A Norton, N Javadpour
Sep 1, 1977·American Journal of Surgery·N L Simstein, K L Mattox
Oct 1, 1977·Archives of General Psychiatry·G GardosR La Brie
Jan 1, 1976·International Pharmacopsychiatry·M M Singh
Apr 1, 1975·Journal of Neurology, Neurosurgery, and Psychiatry·D TarsyC D Marsden
Jul 17, 1975·The New England Journal of Medicine·K L DavisL E Hollister
Aug 1, 1973·The American Journal of Psychiatry·J P Curran
Jan 1, 1970·Acta Neurologica Scandinavica·R Fog, H Pakkenberg
Jan 1, 1973·The American Journal of Psychiatry·H L Klawans
Jan 1, 1974·Neurology·D TarsyD S Sax
Jun 21, 1974·Psychopharmacologia·W E FannG M McKenzie
Jan 1, 1974·Calcified Tissue Research·J M Faccini, S P Teotia
Aug 1, 1973·The American Journal of Psychiatry·W E FannI C Wilson
Dec 1, 1972·The American Journal of Psychiatry·K JusA Jus
Dec 1, 1972·The British Journal of Psychiatry : the Journal of Mental Science·I TurekM Bohm
Aug 1, 1973·Journal of Pharmaceutical Sciences·M M Luckens, M H Malone
Feb 1, 1971·Archives of General Psychiatry·G E Crane, E R Naranjo
Jan 13, 1972·The New England Journal of Medicine·H A PetersS Sato
Mar 16, 1972·The New England Journal of Medicine·R C Duvoisin
Sep 4, 1971·British Medical Journal·S G Carruthers
Oct 1, 1971·Journal of the Neurological Sciences·H L Klawans, R R McKendall
Mar 21, 1970·British Medical Journal·W A MacCallum
May 1, 1971·The British Journal of Psychiatry : the Journal of Mental Science·P F KennedyR J McGuire
Aug 1, 1980·Psychological Medicine·A V MacKayC D Marsden
Dec 1, 1961·The American Journal of Psychiatry·E BRANDRUP

Related Concepts

Antipsychotic Effect
Lingual-Facial-Buccal Dyskinesia
Cholinergic Receptors
Gammalon
Tardive Dyskinesia
Dyskinesia, Medication-Induced
Dopamine Receptor
Clinical Trials
Gamma-Aminobutyric Acid, Zinc Salt (2:1)
Acetylcholine Sulfate (1: 1)

Related Feeds

Ataxias (MDS)

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Ataxias

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Ataxia

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.